Italy’s Ministry of Health made a rapid U-turn on a decree that had intended to classify CBD as a narcotic, which would have effectively put the brakes on the sale of non-medicinal CBD in supplements and food. The reversal comes after a wave of objections from hemp associations in Europe, including the European Industrial Hemp Association (EIHA) and Federcanapa. The situation appears to have arisen from confusion and highlights the need for greater education around the difference between high-dose CBD medicines, such as the one used to treat severe epilepsies, Dravet Syndrome and Lennox-Gastaut Syndrome, and lower dose inclusion of CBD for therapeutic and cosmetic use. The showdown has a silver lining however, as the EIHA and Italian health ministry have now formed a working group to clearly define the status of CBD. Source: La Stampa
CBD
Italian Health Ministry Reverses Ruling to Schedule CBD Narcotic
November 15, 20201 min read
Tags:CBDWellnessScience
Share:
BR
Written by BioMuti Research Team
The BioMuti editorial team combines expertise in biochemistry, herbal medicine, and African ethnobotany to bring you science-backed wellness insights.
Related Articles

CBD
South Africa's Cannabis Opportunity: Serving Local Wellness Needs First
As South Africa's cannabis industry develops, the focus must be on building local value chains that serve domestic wellness needs. Explore the science behind CBD, the regulatory landscape, and how Bio…
June 19, 2026|4 min read

CBD
The Complete Guide to BioMuti Peptides: BPC-157, TB-500, GHK-Cu & More
Your complete guide to BioMuti's full peptide range in South Africa. From BPC-157 and TB-500 to GHK-Cu, NAD+, MOTS-c, and more — explore, compare, and buy.
May 25, 2026|8 min read

CBD
BPC-157 for Recovery: How It Works & Where to Buy in South Africa
Discover how BPC-157 accelerates injury recovery — how it works, protocols, stacking options, and where to buy research-grade BPC-157 in South Africa from BioMuti.
May 25, 2026|5 min read